Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.42 |
| ▸ | PPARA | Q07869 | 7/20 | 0.42 |
| ▸ | DRD2 | P14416 | 4/20 | 0.39 |
| ▸ | DRD4 | P21917 | 4/20 | 0.39 |
| ▸ | DRD3 | P35462 | 4/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20025239 | 0.93 | DRD2 (0.38) | PPARGPPARADRD2DRD4DRD3 | |
| SCHEMBL19989701 | 0.92 | PPARG (0.37) | PPARGPPARADRD2DRD4DRD3 | |
| SCHEMBL19989691 | 0.91 | — | — | |
| SCHEMBL28811903 | 0.89 | DRD2 (0.46) | PPARGPPARADRD2DRD4DRD3 | |
| SCHEMBL28811383 | 0.88 | DRD2 (0.46) | PPARGPPARADRD2DRD4DRD3 | |
| SCHEMBL28810925 | 0.88 | PPARG (0.43) | PPARGPPARADRD2DRD4DRD3 | |
| SCHEMBL28810919 | 0.87 | DRD2 (0.44) | PPARGPPARADRD2DRD4DRD3 | |
| SCHEMBL19989565 | 0.84 | DRD2 (0.43) | PPARGPPARADRD2DRD4DRD3 | |
| SCHEMBL19989622 | 0.81 | DRD3 (0.42) | PPARGPPARADRD2DRD4DRD3 | |
| SCHEMBL19989590 | 0.81 | DRD2 (0.41) | PPARGPPARADRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110088087-B | Tetrahydropyridine derivatives and their use as antibacterial agents | 东亚ST株式会社 | 2022-08-09 | — | — | CN | disclosed |